stockrowRockwell Medical, Inc.
RMTIHealthcare Drug Manufacturers Specialty & Generic
Rockwell Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.3 million, down 31.8% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +32.0%
- Free cash flow
- −12.9%
- Total debt
- −1.73%
Quarter to June 2026, against a year earlier
Follow RMTI
Alert me
Rockwell Medical, Inc. (RMTI) Return on invested capital
Rockwell Medical, Inc.'s return on invested capital over the twelve months to 30 June 2026 was −14.6%, down 0.7 percentage points from fiscal 2025 (−13.9%). Over the past ten years it has ranged from −2,796.5% (fiscal 2021) to 1.86% (fiscal 2024); the current reading is higher than 36% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 0.00% and below the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −13.9% | (15.75) |
| FY2024 | 1.86% | 22.50 |
| FY2023 | −20.6% | 248.13 |
| FY2022 | −268.8% | 2,527.69 |
| FY2021 | −2,796.5% | (2,796.46) |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | 0.00 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| IXHL Incannex Healthcare Inc. compare | 0.00% |
| INCR InterCure Ltd. compare | 0.00% |
| ZYBT Zhengye Biotechnology Holding Limited compare | 0.00% |
| CPHI China Pharma Holdings, Inc. compare | −7.23% |
| TXMD TherapeuticsMD, Inc. compare | −13.8% |
| RMTI Rockwell Medical, Inc. | −14.6% |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. compare | −36.7% |
| CTOR Citius Oncology, Inc. compare | −67.2% |
| SCYX SCYNEXIS, Inc. compare | −110.7% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)